Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2002

View Archived Issues

Baxter submits BLA for rAHF-PFM

Atrix files IND for transmucosal sumatriptan

Nolvadex warnings strengthened

Immune Network presents overview of drug candidate development

Fujisawa seeks Canadian approval for micafungin

Hepatitis B pharmaccine enters phase II

PS-1145 reduces multiple myeloma growth and survival through inhibition of NF-kB activation

Selective glucocorticoid receptor antagonist demonstrates clinical antidepressant activity

Traditional medicinal products with potential in Alzheimer's disease

New IL-4 variant evaluated for safety in phase I trial in MS patients

Favorable NMB characteristics determined for TAAC3 in animals

Pretreatment with Genasense being tested for advanced malignant melanoma

In vitro evidence for efficacy of bosentan in malignant melanoma presented in Paris

Resiquimod prevents recurrence of genital herpes

Selective Lys-gingipain inhibitors for use in periodontitis

Ajinomoto presents novel SGLT2 inhibitors

New PGD2 antagonists for use in upper respiratory tract disorders

Novel analgesic naphthyridines identified at Otsuka

Takeda reports novel CCR5 antagonists and their use in HIV infection

Nociceptin receptor ligands claimed by Nippon Shinyaku

Fampridine-SR enters two phase III trials for chronic spinal cord injury

Inhibitors of NF-kB activation and their use in inflammatory disorders

HuMax-IL-15 effective in mouse model of psoriasis

NeoPharm submits IND for LE-SN-38

CPMP recommends approval of new indication for clopidogrel

Nonapprovable letter issued for Risperdal Consta

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...